ABOUT THIS PODCAST 🔗

Hosts:
Update frequency:
bimonthly
Average audio length:
35 minutes
Guest interviews
Has sponsors
English
United States
28 episodes
since April 27, 2021
episodic

LATEST EPISODE 🔗

Send us Fan Mail Lymphomas represent the most common group of haematological malignancies, encompassing a broad spectrum of biologically and clinically distinct entities. Diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma (MCL) together account for the majorit…

SEARCH PAST EPISODES

Search past episodes of The Hematology Podcast.

PREVIOUS EPISODES

Send us Fan Mail Immune thrombocytopenia, the ITP is increasingly recognized as a complex immune‑mediated disease rather than just a disorder of low platelets. This episode, explores new developments in ITP, focusing on the complex immune disorder as the underlying mechanism of ITP and how immunolo…
Send us Fan Mail Gaucher disease is a rare lysosomal storage disorder that presents with varying prevalence and management approaches across Nordic countries. Despite geographical proximity, these countries show notable differences in disease presentation, diagnostic approaches, and patient care pa…
Send us Fan Mail Hematopoietic stem cell transplantation is a crucial part of the treatment of many hematological malignancies. One important effect is alteration of the immune system. To overcome this, vaccinations after hematopoietic stem cell transplantation are a vital part of post-transplant c…
Send us Fan Mail The integration of artificial intelligence (AI) into routine clinical practice is poised to revolutionize the diagnosis and treatment of hematologic diseases. AI-based models are already capable of automatically identifying cell populations including malignant cells, and facilitati…
Send us Fan Mail Immune Thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count, which can lead to increased bleeding and bruising. In this episode, we will discuss the pathophysiology, clinical implications, and advancements in ITP. Our guest today, Professor Waleed …
Send us Fan Mail A new genomic definition of high-risk multiple myeloma (HR-MM) has been recently proposed by IMS/IMWG. The associated peer-reviewed publication is planned to be released in Spring 2025. Expert guest in this episode is Professor Monique Minnema, haematologist at the University Hospi…
Send us Fan Mail In this episode of The Hematology Podcast, we will delve into the complex world of thrombotic microangiopathy, or TMA. This condition encompasses a group of disorders characterized by small blood clots forming in the smallest blood vessels, leading to various complications. Diagnos…
Send us Fan Mail In this episode, we dive into the fascinating world of liquid biopsy-derived DNA as a revolutionary tool for comprehensive mutation profiling in multiple myeloma. This innovative approach offers a non-invasive way to analyse genetic alterations, potentially transforming how we diag…
Send us Fan Mail In this episode, we focus on Thalassemia major, a severe form of the disease. In a previous episode, we discussed Thalassemia minor and intermedia with Professor Dr. Bart Biemond from Amsterdam UMC. Now, we will delve deeper into the challenges and treatments associated with Thalas…
Disclaimer: The podcast and artwork embedded on this page are from Sanofi, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.